Hypertensive disorders of pregnancy and subsequent risk of solid cancer - A nationwide cohort study

International Journal of Cancer

Volumn 139, Issue 1, 2016, Pages 58-64

  Behrens, Ida ^a   Basit, Saima ^a   Jensen, Allan ^b   Lykke, Jacob Alexander ^c   Nielsen, Lars Peter ^a   Wohlfahrt, Jan ^a   Kjær, Susanne K ^b,d   Melbye, Mads ^a,d,e   Boyd, Heather Allison ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; cancer; epidemiology; hypertensive disorders of pregnancy

Indexed keywords

ADULT; AGE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL HISTORY; PRIORITY JOURNAL; RISK REDUCTION; SMOKING; SOLID TUMOR; URINARY TRACT CANCER; COMPLICATION; HYPERTENSION, PREGNANCY-INDUCED; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PREGNANCY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84961575869     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30065     Document Type: Article

References (48)

1. American College of Obstetricians and Gynocologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122-31.
2. Abalos E, Cuesta C, Grosso AL, et al., Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 2013; 170: 1-7.
3. Powe CE, Levine RJ, Karumanchi SA., Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856-69.
4. Levine RJ, Lam C, Qian C, et al., Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005.
5. Levine RJ, Maynard SE, Qian C, et al., Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-83.
6. Rana S, Powe CE, Salahuddin S, et al., Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012; 125: 911-9.
7. Noori M, Donald AE, Angelakopoulou A, et al., Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010; 122: 478-87.
8. Rasmussen LG, Lykke Ja, Staff AC., Angiogenic biomarkers in pregnancy: defining maternal and fetal health. Acta Obstet Gynecol Scand 2015; 94: 820-32.
9. Wolf M, Hubel Ca, Lam C, et al., Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 2004; 89: 6239-43.
10. Folkman J., Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
11. Kieran MW, Kalluri R, Cho Y-J., The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Cold Spring Harb Perspect Med 2012; 2: a006593
12. Kvehaugen AS, Dechend R, Ramstad HB, et al., Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 2011; 58: 63-9.
13. Sandvik MK, Leirgul E, Nygärd O, et al., Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol 2013; 209: 569.e1-e10.
14. Gaugler-Senden IPM, Tamsma JT, van der Bent C, et al., Angiogenic Factors in Women Ten Years after Severe Very Early Onset Preeclampsia. PLoS One 2012; 7: e43637
15. Mutter WP, Karumanchi SA., Molecular mechanisms of preeclampsia. Microvasc Res 2008; 75: 1-8.
16. Nechuta S, Paneth N, Velie EM., Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control 2010; 21: 967-89.
17. Gilbert JS., The opposing roles of anti-angiogenic factors in cancer and preeclampsia. Front Biosci 2012; E4: 2652-69.
18. Pacheco NLP, Andersen A-MN, Kamper-Jørgensen M., Preeclampsia and breast cancer: The influence of birth characteristics. Breast 2015; 24: 613-7.
19. Opdahl S, Romundstad PR, Alsaker MDK, et al., Hypertensive diseases in pregnancy and breast cancer risk. Br J Cancer 2012; 107: 176-82.
20. Ekbom A, Hsieh CC, Lipworth L, et al., Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 1997; 89: 71-6.
21. Bellamy L, Casas J-P, Hingorani AD, et al., Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Bmj 2007; 335: 974
22. Cnattingius S, Torräng A, Ekbom A, et al., Pregnancy characteristics and maternal risk of breast cancer. Jama 2005; 294: 2474-80.
23. Walfisch A, Kessous R, Davidson E, et al., Pre-eclampsia and future female malignancy. Hypertens Pregnancy 2015; 1955: 1-8.
24. Calderon-Margalit R, Friedlander Y, Yanetz R, et al., Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 2009; 200: 63.e1-5.
25. Aagaard-Tillery KM, Stoddard GJ, Holmgren C, et al., Preeclampsia and subsequent risk of cancer in Utah. Am J Obstet Gynecol 2006; 195: 691-9.
26. Schmidt M, Pedersen L, Sørensen HT., The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014; 29: 541-9.
27. Pedersen CB., The Danish Civil Registration System. Scand J Public Health 2011; 39: 22-5.
28. Knudsen LB, Olsen J., The Danish Medical Birth Registry. Dan Med Bull 1998; 45: 320-3.
29. Lynge E, Sandegaard JL, Rebolj M., The Danish National Patient Register. Scand J Public Health 2011; 39: 30-3.
30. Storm HH, Michelsen EV, Clemmensen IH, et al., The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997; 44: 535-9.
31. Gjerstorff ML., The Danish Cancer Registry. Scand J Public Health 2011; 39: 42-5.
32. Frisch M, Melbye M., New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995; 141: 916-22.
33. Frentz G, Olsen JH., Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 1999; 140: 237-42.
34. England L, Zhang J., Smoking and risk of preeclampsia: a systematic review. Front Biosci 2007; 12: 2471-83.
35. Hecht SS., Cigarette smoking: Cancer risks, carcinogens, and mechanisms. Langenbeck's Arch Surg 2006; 391: 603-13.
36. Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual, 7th edn. New York, NY: Springer, 2010.
37. Lin DY, Wei LJ, Ying Z., Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993; 80: 557-72.
38. Irgens HU, Reisaeter L, Irgens LM, et al., Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Bmj 2001; 323: 1213-7.
39. Funai EF, Friedlander Y, Paltiel O, et al., Long-term mortality after preeclampsia. Epidemiology 2005; 16: 206-15.
40. Kim JS, Kang EJ, Woo OH, et al., The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis. Acta Oncol 2013; 52: 1643-8.
41. Carbillon L., Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile. Br J Cancer 2012; 107: 1915-6.
42. Carbillon L, Delahosseraye C., Preeclampsia and subsequent breast cancer risk. Cancer Causes Control 2015; 26: 955-6.
43. Vatten LJ, Romundstad PR, Jenum Pa, et al., Angiogenic balance in pregnancy and subsequent breast cancer risk and survival: a population study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2074-8.
44. Viswanathan AN, Feskanich D, De Vivo I, et al., Smoking and the risk of endometrial cancer: results from the nurses' health study. Int J Cancer 2005; 114: 996-1001.
45. Zhou B, Yang L, Sun Q, et al., Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008; 121: 501-508.e3.
46. Faulds MH, Dahlman-Wright K., Metabolic diseases and cancer risk. Curr Opin Oncol 2012; 24: 58-61.
47. Duckitt K, Harrington D., Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. Bmj 2005; 330: 565
48. Klemmensen AK, Olsen SF, Osterdal ML, et al., Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 2007; 166: 117-24.